Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$5.23 - $7.82 $262,556 - $392,579
-50,202 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$7.29 - $10.97 $21,804 - $32,811
-2,991 Reduced 5.62%
50,202 $377,000
Q3 2021

Nov 08, 2021

SELL
$9.01 - $12.01 $20,290 - $27,046
-2,252 Reduced 4.06%
53,193 $479,000
Q2 2021

Aug 09, 2021

BUY
$10.17 - $12.64 $1,261 - $1,567
124 Added 0.22%
55,445 $663,000
Q1 2021

May 13, 2021

SELL
$10.88 - $17.05 $35,904 - $56,265
-3,300 Reduced 5.63%
55,321 $693,000
Q4 2020

Feb 09, 2021

SELL
$9.23 - $18.18 $738,963 - $1.46 Million
-80,061 Reduced 57.73%
58,621 $915,000
Q3 2020

Nov 09, 2020

SELL
$9.38 - $12.48 $58,381 - $77,675
-6,224 Reduced 4.3%
138,682 $1.31 Million
Q2 2020

Aug 12, 2020

SELL
$6.21 - $11.83 $22,331 - $42,540
-3,596 Reduced 2.42%
144,906 $1.3 Million
Q1 2020

May 04, 2020

BUY
$5.05 - $8.85 $1,631 - $2,858
323 Added 0.22%
148,502 $946,000
Q4 2019

Feb 12, 2020

SELL
$8.03 - $11.7 $802,172 - $1.17 Million
-99,897 Reduced 40.27%
148,179 $1.24 Million
Q3 2019

Nov 12, 2019

SELL
$9.05 - $12.22 $28,055 - $37,882
-3,100 Reduced 1.23%
248,076 $2.25 Million
Q2 2019

Aug 16, 2019

BUY
$8.75 - $13.03 $1.23 Million - $1.83 Million
140,450 Added 126.84%
251,176 $2.71 Million
Q1 2019

May 13, 2019

SELL
$7.72 - $12.81 $62,593 - $103,863
-8,108 Reduced 6.82%
110,726 $1.06 Million
Q4 2018

Feb 05, 2019

BUY
$9.51 - $16.6 $24,592 - $42,927
2,586 Added 2.22%
118,834 $1.36 Million
Q3 2018

Nov 07, 2018

SELL
$13.05 - $19.05 $26,765 - $39,071
-2,051 Reduced 1.73%
116,248 $1.97 Million
Q2 2018

Aug 10, 2018

SELL
$13.9 - $19.8 $135,135 - $192,495
-9,722 Reduced 7.59%
118,299 $1.68 Million
Q1 2018

May 08, 2018

BUY
$16.7 - $26.35 $8,350 - $13,175
500 Added 0.39%
128,021 $2.43 Million
Q4 2017

Feb 13, 2018

BUY
$11.6 - $17.35 $1.48 Million - $2.21 Million
127,521
127,521 $2.09 Million

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $374M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.